Simplification from protease inhibitors to once-or twice-daily raltegravir: The ODIS trial

1. Vispo, E.
2. Barreiro, P.
3. Maida, I.
4. Mena, A.
5. Blanco, F.
6. Rodríguez-Novoa, S.
7. Morello, J.
8. Jimenez-Nacher, I.
9. Gonzalez-Lahoz, J.
10. Soriano, V.